Rational design of 4-amino-5,6-diaryl-furo[2,3-d]pyrimidines as potent glycogen synthase kinase-3 inhibitors
摘要:
4-Amino-5,6-diaryl-furo[2,3-d] pyrimidines have been identified as inhibitors of glycogen synthase kinase-3b (GSK-3 beta). One representative derivative, 4-amino-5-(4-(benzenesulfonylamino)-phenyl)-6-(3-pyridyl)-furo[2,3-d] pyrimidine (12) exhibited potent GSK-3b inhibitory activity in low nanomolar level of IC50. The binding mode was proposed from a docking study. (C) 2008 Elsevier Ltd. All rights reserved.
Rational design of 4-amino-5,6-diaryl-furo[2,3-d]pyrimidines as potent glycogen synthase kinase-3 inhibitors
摘要:
4-Amino-5,6-diaryl-furo[2,3-d] pyrimidines have been identified as inhibitors of glycogen synthase kinase-3b (GSK-3 beta). One representative derivative, 4-amino-5-(4-(benzenesulfonylamino)-phenyl)-6-(3-pyridyl)-furo[2,3-d] pyrimidine (12) exhibited potent GSK-3b inhibitory activity in low nanomolar level of IC50. The binding mode was proposed from a docking study. (C) 2008 Elsevier Ltd. All rights reserved.
Furo- and thienopyrimidine derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such furo- and thienopyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF
申请人:Adams Jerry Leroy
公开号:US20080287466A1
公开(公告)日:2008-11-20
Furo- and thienopyrimidine derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such furo- and thienopyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP1425284A2
公开(公告)日:2004-06-09
US7427623B2
申请人:——
公开号:US7427623B2
公开(公告)日:2008-09-23
[EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSES CHIMIQUES
申请人:GLAXOSMITHKLINE K K
公开号:WO2003022852A2
公开(公告)日:2003-03-20
Furo- and thienopyrimidine derivatives, of Formula (I), wherein X is O or S; which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such furo- and thienopyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.